News
$Precision BioSciences(DTIL.US$ Reuters· 3 mins ago
Precision BioSciences Announces Receipt of FDA Fast Track Designation for Ecur-506, Iecure’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (Otc) Deficiency
Precision BioSciences Announces Receipt of FDA Fast Track Designation for Ecur-506, Iecure’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (Otc) Deficiency
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
